Market News / Story
Medincell Achieves Major Milestone with U.S. FDA Approval of WELTRUZA™ (olanzapine)
BusinessWire ·
BusinessWire reports: Medincell (Paris:MEDCL) Medincell will host Investor webcast today to discuss the implications of the approval for the Company and answer questions from analysts. Webcast Details Date: Friday, October 9, 2026 Time: 4:00 p.m. CEST / 10:00 a.m. ET Webcast: https://www.medincell.com/investor-webcast-oct-9-2026/ A replay of the webcast will be available on Medincell's website following the event. Medincell (Euronext: MEDCL) achieves major milestone with the announcement by…